Re: Warning: Long - Thoughts on Management
|
7
|
Resverlogix Corp.
|
Mar 26, 2021 04:10PM
|
Biotech Valuation
|
11
|
Resverlogix Corp.
|
Mar 28, 2021 07:07PM
|
Re: Biotech Valuation
|
8
|
Resverlogix Corp.
|
Mar 31, 2021 12:38AM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
5
|
Resverlogix Corp.
|
Apr 15, 2021 03:06PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 04:40PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 15, 2021 06:08PM
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 03:26PM
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
6
|
Resverlogix Corp.
|
Apr 21, 2021 10:20AM
|
Comments on today's annual update
|
12
|
Resverlogix Corp.
|
Jun 22, 2021 08:34PM
|
To Be or Not to Be?
|
9
|
Resverlogix Corp.
|
Aug 10, 2021 01:05AM
|
Re: To Be or Not to Be?
|
7
|
Resverlogix Corp.
|
Aug 11, 2021 08:03AM
|
Re: Financials
|
2
|
Resverlogix Corp.
|
Aug 17, 2021 08:24PM
|
Re: To Be or Not to Be?
|
8
|
Resverlogix Corp.
|
Aug 19, 2021 01:06PM
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 20, 2021 05:45PM
|
Re: Apparently Don spoke other day, but not at ESC
|
6
|
Resverlogix Corp.
|
Aug 31, 2021 01:41AM
|
Any day now?
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 12:18AM
|
We need safe and effective Covid therapies
|
6
|
Resverlogix Corp.
|
Sep 28, 2021 11:50PM
|
Re: We need safe and effective Covid therapies
|
4
|
Resverlogix Corp.
|
Sep 29, 2021 09:05AM
|
Re: Optimistic
|
4
|
Resverlogix Corp.
|
Oct 14, 2021 06:04PM
|
Re: Optimistic
|
8
|
Resverlogix Corp.
|
Oct 14, 2021 09:01PM
|